Drug interactions
Hepatitis A vaccine inactivated + Ublituximab
Severity: Moderate
Hepatitis A vaccine inactivated and Ublituximab: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
B-cell depletion by ublituximab can substantially reduce antibody responses to inactivated vaccines. Patients may have inadequate protection from hepatitis A vaccination given during treatment.
What this interaction means in plain words
Hepatitis A vaccine inactivated and Ublituximab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Hepatitis A vaccine inactivated belongs to Anti Virals; Ublituximab belongs to Miscellaneous.
Why it happens
Anti-CD20 B-cell depletion impairs humoral response to vaccine antigens.
What to do
Vaccinate at least 2 weeks before starting ublituximab; if vaccinated during treatment, check serologic response and revaccinate if needed.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Hepatitis A vaccine inactivated and Ublituximab, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Hepatitis A vaccine inactivated
- Adalimumab + Hepatitis A vaccine inactivated Moderate
- Alefacept + Hepatitis A vaccine inactivated Moderate
- Anakinra + Hepatitis A vaccine inactivated Moderate
- Anti-thymocyte + Hepatitis A vaccine inactivated Moderate
- Antithymocyte globulin equine + Hepatitis A vaccine inactivated Moderate
- Antithymocyte globulin rabbit + Hepatitis A vaccine inactivated Moderate
Other interactions of Ublituximab
Frequently asked questions
Can I take Hepatitis A vaccine inactivated with Ublituximab?
MediHelp rates the interaction as moderate. Hepatitis A vaccine inactivated and Ublituximab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. B-cell depletion by ublituximab can substantially reduce antibody responses to inactivated vaccines. Patients may have inadequate protection from hepatitis A vaccination given during treatment.
How serious is the interaction between Hepatitis A vaccine inactivated and Ublituximab?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Vaccinate at least 2 weeks before starting ublituximab; if vaccinated during treatment, check serologic response and revaccinate if needed.
What other medicines interact with Hepatitis A vaccine inactivated?
MediHelp also lists interactions of Hepatitis A vaccine inactivated with, for example, Adalimumab, Alefacept, Anakinra. The full list is on the Hepatitis A vaccine inactivated page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
